Trichostatin A (TSA), a histone deacetylase inhibitor, strongly increases acetylation of the N-terminal tails of histone H3. Many studies have correlated the function of TSA with the hyperacetylation of histone. Although histone H3 is known to be phosphorylated, the effect of acetylation on phosphorylation is not known. Here, we report that in JB6 cells, TSA induces both acetylation at lysine 9 and phosphorylation at serine 28 of histone H3. UVB irradiation, which is known to induce phosphorylation at serine 28, did not significantly affect phosphorylation of histone H3 in TSA-pretreated JB6 cells. In contrast, TSA markedly increased phosphorylation and acetylation of histone H3 in UVB-pretreated JB6 cells. TSA strongly activated MAP kinases. Moreover, PD98059 and SB202190 inhibited TSA-induced phosphorylation but not acetylation of histone H3. Dominant negative mutant ERK2 and dominant negative mutant p38 kinase blocked TSA-stimulated phosphorylation of histone H3 at serine 28. The results indicate that TSAinduced phosphorylation of histone H3 at serine 28 occurs through activation of the MAP kinase pathway and phosphorylated histone H3 is more sensitive to TSAinduced hyperacetylation. The facilitation of phosphorylation and acetylation of histone H3 induced by TSA may play a critical regulatory role in chromatin remodeling and gene expression.
Introduction
A role for the post-translational modifications of acetylation and phosphorylation of histone in transcription processes and in the remodeling of chromatin structure has been established. A number of histone acetyltransferases (HATs) and histone deacetylases (HDACs) exist in eucaryotic cells and maintain the balance between acetylation and deacetylation Brownell et al., 1996; Mizzen et al., 1996; Roth and Allis, 1996; Yang et al., 1996; Grozinger and Schreiber, 2000) . Acetylation of histone tails disrupts higher-order chromatin folding, promotes the solubility of chromatin at physiologic ionic strength, and maintains the unfolded structure of the transcribed nucleosome to allow access for transcriptional coactivators and transcription to occur . In contrast to HATs, recruitment of HDACs can lead to repression of transcription. Chromatin regions of transcription are associated with dynamically acetylated histone (Davie and Chadee, 1998) . When the balance of activity of these two enzymes favors deacetylation, the chromatin region will take on a repressive higher-order structure of chromatin . Besides acetylation of histones, the core histones and histone H1 undergo phosphorylation on specific serine and threonine residues in chromosome condensation during mitosis (Bradbury, 1992; Koshland and Strunnikov, 1996) . Phosphorylation of histone H3 N-terminal serine 10 is closely related to both the induction of immediate-early (IE) genes, including proto-oncogenes c-fos and c-jun, and to chromatin remodeling and chromosome condensation during mitosis and meiosis (Wei et al., 1998; Chadee et al., 1999; Sassone-Corsi et al., 1999; Thomson et al., 1999; Clayton et al., 2000; Salvador et al., 2001) . In addition, a recent study has shown that phosphorylation of histone H3 at serine 28 also occurs in chromosomes predominantly during early mitosis and coincides with the initiation of mitotic chromosome condensation in various mammalian cell lines (Goto et al., 1999) . Very recently, we reported that UVB-induced phosphorylation of histone H3 at serine 28 is mediated by MAP kinases/MSK1 pathways (Zhong et al., 2001a, b) .
In the histone H3 N-terminal tail, lysines 9, 14, 18, and 23 are acetylated and serines 10 and 28 are phosphorylated (Honda et al., 1975; Mahadevan et al., 1991) . Multiple covalent modifications exist in the Nterminal tail of histone H3, but the relation existing between them remains to be fully elucidated. Recent studies showed that stimulation of mammalian cells by epidermal growth factor (EGF) results in rapid and sequential phosphorylation and acetylation of H3 and these modified H3 molecules are preferentially associated with the induction of IE genes (Cheung et al., 2000; Clayton et al., 2000) . Phosphorylation of histone H3 at serine 10 is functionally linked to GCN5-mediated acetylation of histone H3 at lysine 14 (Lo et al., 2000) . Phosphorylation of H3 was also shown to be acetylated in butyrate-pretreated mammalian cells following EGF stimulation (Barratt et al., 1994) . EGF or EGF plus anisomycin induced phosphorylation of histone H3 after cells were treated with butyrate or trichostatin A (TSA) for several hours (Clayton et al., 2000; Lo et al., 2000) . However, phosphorylation of histone H3 at serine 10 and serine 28 is a rapid and transient occurrence. Histone H3 phosphorylation usually disappears 2 h after UVB irradiation treatment (Zhong et al., 2000 . Previous studies on the synergic relation of phosphorylation and acetylation of histone H3 only involved phosphorylation of serine 10 and acetylation of lysine 9 or lysine 14 (Cheung et al., 2000; Clayton et al., 2000; Lo et al., 2000; Salvador et al., 2001 ), but not phosphorylation of serine 28. Most of the signaling effects of HDAC inhibitors, TSA or butyrate, are attributed to the acetylation of histone. In the present study, we report that TSA induces phosphorylation of histone H3 at serine 28 and acetylation of histone H3 at lysine 9 in vivo. This study represents the first example of modification of both acetylation and phosphorylation by the histone deacetylase inhibitor, TSA.
Results
TSA induces phosphorylation of histone H3 at serine 28 and acetylation of histone H3 at lysine 9
Histones in mammalian cells treated with TSA are acetylated to an unusually high extent. To study the possible relation between acetylation and phosphorylation of histone H3, we first treated mouse epidermal JB6 cells with different amounts of TSA and analysed H3 acetylation and phosphorylation by Western blot. TSA induced phosphorylation of H3 at serine 28 in a dosedependent manner (Figure 1a) . The highest level of phosphorylation of H3 at serine 28 was induced by 30 ng/ml of TSA. A time course study showed that compared to respective controls in JB6 cells, 30 ng/ml of TSA induced a rapid and transient phosphorylation of histone H3 at serine 28 (Figure 1e ). The levels of phosphorylation of histone H3 at serine 28 peaked at 60 min after TSA treatment and then decreased by 90 min (Figure 1e ). On the other hand, TSA had no effect on phosphorylation of histone H3 at serine 10 (data not shown). TSA also stimulated acetylation of H3 at lysine 9 above control values ( Figure 1c ) and the acetylation was sustained for at least 90 min (Figure 1f ). Total histone H3 protein levels were unchanged ( Figure  1b,d,g ).
TSA induces phosphorylation of ERKs, JNKs, and p38 kinase Phosphorylation of histone H3 at serine 10 and 28 is mediated by different signal transduction pathways depending on the specific stimulation or stress (Sassone-Corsi et al.,. 1999; Thomson et al., 1999; Lo et al., 2000; Zhong et al., 2000 Zhong et al., , 2001a Salvador et al., 2001 ). In our previous study, we showed that MAP kinases mediated UVB-induced phosphorylation of histone H3 at serine 10 and 28 (Zhong et al., 2000 . To investigate whether MAP kinases are involved in TSAinduced phosphorylation of histone H3 at serine 28, we used antibodies against phosphorylation of ERKs, p38 kinase or JNKs to study the activation of these MAP kinases. Results show that in JB6 cells, TSA strongly induced phosphorylation of ERKs and JNKs in a dosedependent manner (Figure 2a,b) . The highest peak of phosphorylation of ERKs and JNKs appeared to occur with 30 ng/ml of TSA, which seems to be consistent with the optimal dose for peak H3 phosphorylation ( Figure 1a) . TSA also induced phosphorylation of p38 kinase (Figure 2c ) but to a lesser degree. These results indicate that TSA induces phosphorylation of MAP kinases in a dose-dependent manner.
Inhibitors of MAP kinase activation specifically block TSA-induced phosphorylation, but not acetylation of histone H3
To determine the possible role of MAP kinases in mediating TSA-induced histone H3 phosphorylation at serine 28 in vivo, we first examined the influence of specific chemical inhibitors of MEK1 and p38 kinase on TSA-induced H3 phosphorylation at serine 28 in JB6 PD98059 is a specific inhibitor of the activation of MEK1 (Alessi et al., 1995; Oh-hashi et al., 1999; Smalley et al., 1999) . We have reported previously that PD98059 inhibits UV-induced phosphorylation of ERKs, but has no effect on p38 kinase or JNKs phosphorylation (Zhang et al., 2001a, b; She et al., 2002) . Our results here show that PD98059 markedly inhibited TSAinduced phosphorylation of histone H3 at serine 28 ( Figure 3a ), but had no effect on acetylation of histone H3 at lysine 9 ( Figure 3b ). This result suggests that ERKs may be involved in TSA-induced phosphorylation of H3 at serine 28. Another compound, SB202190, is a specific inhibitor of p38 kinase (Tan et al., 1996; Huang et al., 1999b) . We have also reported previously that SB202190 inhibits UV-induced phosphorylation of p38 kinase, but has no effect on ERKs or JNKs phosphorylation (Zhang et al., 2001a; She et al., 2002) . Pretreatment of cells with 0.5-4 mm SB202190 also inhibited TSA-induced phosphorylation of H3 at serine 28 ( Figure 3d ), but had no effect on acetylation of histone H3 at lysine 9 ( Figure 3e ). Together, these data indicate that the activation of ERKs and p38 kinase may be involved in TSA-induced phosphorylation of H3 at serine 28, but probably are not involved in TSA-induced acetylation of histone H3 at lysine 9.
The above results indicated that TSA induced phosphorylation of MAP kinases ( Figure 2 ) and the MAP kinase inhibitor, PD98059 and SB202190 inhibited TSA-induced phosphorylation of H3 at serine 28 ( Figure 3 ). Expression of dominant negative mutants of MAP kinases generally provides a more specific inhibitor than chemical inhibitors. For example, expression of dominant negative mutants of ERK1 (DNM-ERK1), p38 kinase (DNM-p38), and JNK1 (DNM-JNK1) in JB6 cells has been previously shown to block specifically UVB-induced phosphorylation of ERKs (Tan et al., 1996; Watts et al., 1998; Huang et al., 1999a, b), p38 kinase (Raingeaud et al., 1995; Rincon et al., 1998) , and JNKs (Derijard et al., 1994) , respectively. In addition, we have shown that DNM-ERK2 specifically inhibits phosphorylation of ERKs, but has no effect on phosphorylation of p38 kinase or JNKs (Zhang et al., 2001a, b) ; DNM-p38 specifically inhibits phosphorylation of p38 kinase, but has no effect on phosphorylation of ERKs (Zhang et al., 2001a, b) ; and expression of DNM-JNK1 inhibits JNK1 phosphorylation but has no effect on ERKs phosphorylation . Therefore, to further identify the role of MAP kinases in TSA-induced phosphorylation of H3, we used JB6 cells expressing DNM-ERK2, DNM-p38, or DNM-JNK1 to determine the level of TSA-induced phosphorylation of histone H3 at serine 28. Compared with wild-type cells, cells expressing DNM-ERK2 (Figure 4a ) or DNM p38 (Figure 4b ) inhibited the TSA-induced phosphorylation of H3 at serine 28. However, expression of DNM-JNK1 had no effect on TSA-induced phosphorylation (Figure 4c ). These results further indicate that ERKs and p38 kinase mediate TSA-induced H3 phosphorylation at serine 28.
TSA and UVB coinduce phosphorylation of histone H3 at serine 28 in vivo Our previous studies showed that UVB strongly induces phosphorylation of histone H3 at serine 28, but had no Figure 2 TSA induces phosphorylation of ERKs, p38 kinase, and JNKs in JB6 cells. Cells were cultured in 5% FBS/MEM until they reached 85% confluence and then were starved in 0.1% FBS/MEM for 48 h. Cells were incubated for an additional 2 h in fresh 0.1% FBS/MEM and then treated with various amounts of TSA as indicated (ng/ml) and subsequently incubated for an additional 30 min. Media were moved and cells were washed two times with cold phosphate-buffered saline (PBS). Cells were harvested with 1 Â SDS-PAGE sample buffer. Phosphorylation of ERKs, p38 kinase, and JNKs was detected with rabbit antiphospho-p42/44 MAP kinase, antiphospho-p38 kinase, and antiphospho-JNKs, respectively. Phosphorylation of ERKs (a), p38 kinase (c), and JNKs (b) was induced by TSA. b-Actin (d) was used as an internal control to monitor equal protein loading. The arrows indicate the positions of phosphorylated ERKs, p38 kinase, JNKs, and total actin protein. The figures are representative of at least three separate experiments Figure 3 PD98059 and SB202190 inhibit TSA-induced phosphorylation of H3 at serine 28 but have no effect on TSA-induced acetylation of H3 at lysine 9 in JB6 C1 41 cells. (a-c) Inhibition of TSA-induced phosphorylation of histone H3 at serine 28 by PD98059. Cells were treated with various concentrations of PD98059 for 1 h and then treated with 30 ng/ml of TSA. Cells were incubated for an additional 30 min. Incubation with PD98059 resulted in a dose-response inhibition of TSA-induced phosphorylation of H3 at serine 28 (a, phospho-H3-S28), but had no effect on acetylation of histone H3 at lysine 9 (b, acetyl-H3-K9). Total histone H3 protein (c) was detected in a parallel blot using antihistone H3. (d-f) Inhibition of TSA-induced phosphorylation of histone H3 at serine 28 by SB202190. Cells were treated with TSA after pretreatment with SB202190 as above. SB202190 slightly inhibited phosphorylation of histone H3 at serine 28 (d), but had no effect on acetylation of histone H3 at lysine 9 (e). Total histone H3 protein (f) was detected in a parallel blot using antihistone H3. The figures are representative of at least three separate experiments Trichostatin A induces phosphorylation of histone H3 S Zhong et al effect on acetylation of this protein in JB6 cells ). On the other hand, TSA treatment of cells for several hours has been shown to cause a hyperacetylation of histone H3 (Barratt et al., 1994; Clayton et al., 2000) . Therefore, treatment with UVB irradiation prior to TSA treatment provides a means to study acetylation of prephosphorylated histone H3 and TSA treatment prior to UVB treatment provides a means to study phosphorylation of preacetylated histone H3 in vivo. However, phosphorylation of histone H3 is a rapid and transient event and UVB-induced histone H3 phosphorylation at serine 10 or serine 28 is barely detectable after 2 h (Zhong et al., 2000 . To determine whether a synergy exists between phosphorylation and acetylation of histone H3, we pretreated JB6 cells with TSA for 2 h and subsequently exposed the cells to UVB (4 kJ/m 2 ) and then determined the level of phosphorylated histone H3 at serine 28 and acetylated histone H3 at lysine 9. TSA alone induced about a twofold increase in phosphorylation of histone H3 at serine 28 (Figure 5a These results imply that acetylation of histone H3 by TSA has no effect on phosphorylation of histone H3. In addition, we tested the reverse possibility, that is, whether phosphorylation of histone H3 at serine 28 affects acetylation of this protein at lysine 9. After UVB irradiation, JB6 cells were treated with TSA and results showed that TSA induced an additional increase in phosphorylation of histone H3 at serine 28 (Figure 5a ,b, Figure 4 TSA-induced phosphorylation of H3 at serine 28 is inhibited in cells expressing DNM-ERK2 or DNM-p38 kinase, but not DNM JNK1. Equivalent numbers of JB6 cells or cells expressing DNM-ERK2, DNM-p38 kinase, or DNM-JNK1 were seeded into 10-cm dishes and cultured in 5% FBS/MEM until they reached 85% confluence and then were starved in 0.1% FBS/MEM for 48 h with one change of medium after 24 h. Cells were then incubated for 2 h in fresh 0.1% FBS/MEM, and then treated or not treated with various concentrations of TSA as indicated. Phosphorylation of H3 at serine 28 was strongly induced by TSA in JB6 cells (a-c). Phosphorylation of histone H3 at serine 28 was markedly blocked in JB6/DNM-ERK2 cells (a); inhibited in JB6/DNM-p38 kinase cells (b); but was unaffected in JB6/DNM-JNK1 cells (c). Total H3 protein was detected in a parallel blot using anti-histone H3. The arrows indicate phosphorylation of H3 at serine 28 or total histone H3 proteins and ''C'' denotes control or untreated cells. The figures are representative of at least three separate experiments Figure 5 TSA and UVB coinduces phosphorylation of histone H3 at serine 28. JB6 cells were cultured in 5% FBS/MEM until they reached 85% confluence and then were starved in 0.1% FBS/MEM for 48 h. Cells were incubated for an additional 2 h in fresh 0.1% FBS/MEM. They were treated as follows: (1) 
Discussion
In this study, we show that TSA induced phosphorylation of histone H3 at serine 28 and acetylation of histone H3 at lysine 9. TSA-induced phosphorylation of this protein was inhibited by PD98059 and SB202190, and decreased in cells expressing DNM-ERK2 and DNMp38, but not by DNM-JNK1. However, TSA-induced acetylation of histone at lysine 9 was not affected by these inhibitors. Prephosphorylation of histone H3 at serine 28 induced by UVB potentiated the acetylation of histone H3 at lysine 9, but preacetylation of histone H3 at lysine 9 had no effect on UVB-induced phosphorylation at serine 28. Taken together, these data indicate that TSA is not only an inhibitor of HDACs resulting in an increased acetylation of histone H3, but is also an effective inducer of phosphorylation of histone H3 (serine 28).
The balance between acetylation and deacetylation of core histones is regulated by HATs and HDACs. HDACs catalyze the removal of acetyl groups of lysine residues clustered near the amino terminus of core histones and the process is associated with transcriptional repression (Struhl, 1998; Finnin et al., 1999) . The treatment of mammalian cells with potent inhibitors of HDACs such as TSA or trapoxin was shown to result in increased expression of a variety of genes (Kijima et al., 1993; Yoshida et al., 1995) . At very low concentrations, inhibitors of HDACs induce hyperacetylation of core histones, which is accompanied by characteristic blockage of the cell cycle as well as by various cellular phenotypic changes (Medina et al., 1997; Dangond and Gullans, 1998; Chen and Townes, 2000; Furumai et al., 2001) . Usually, TSA is used only as an HDACs inhibitor to increase acetylation of core histones, but whether TSA induces phosphorylation of core histones remain to be determined. Based on our recent findings regarding phosphorylation of histone H3 at serine 10 and 28 (Zhong et al., 2000 , we further investigated the relation between phosphorylation and acetylation of histone H3. We found that TSA strongly induced phosphorylation of histone H3 at serine 28 (Figure 1 ), but phosphorylation of histone H3 at serine 10 by TSA was not detected (data not shown). However, TSAinduced acetylation of histone H3 at lysine 9 could affect the conformation of histone H3 so that in JB6 cells the antibody against phosphorylated histone H3 at serine 10 was not reactive. Phosphorylation of histone H3 at serine 28 by TSA is dose and time dependent (Figure 1a,  b) . TSA-induced phosphorylation of histone H3 at serine 28, but not acetylation of histone H3 at lysine 9, was inhibited by MEK inhibitor, PD98059, and by the p38 kinase inhibitor, SB202190, and also in cells expressing DNM-ERK2 or DNM-p38 kinase. This suggests that ERKs and p38 kinase mediate TSAinduced phosphorylation of histone H3 at serine 28, but have no role in the acetylation of histone H3 at lysine 9. Our findings support the idea that the HDAC inhibitor, TSA, induces acetylation of histone H3 accompanied by phosphorylation. However, phosphorylation and acetylation of histone H3 appear to be mediated by different pathways.
A large number of covalent modifications such as acetylation, phosphorylation, and methylation occur at the amino-terminal tails of core histones, particularly H3 and H4. Moreover, the interdependence of the different histone tail modifications for the integration of transcriptional output or higher-order chromatin organization is currently unclear (Rea et al., 2000) . Whether these modifications positively or negatively affect one another remains to be determined . A recent study indicated that the phosphorylated H3-S10 peptide and acetylated H3-K9 peptide inhibited SUV39H1-dependent methylation at H3-K9 (Rea et al., 2000) . However, phosphorylated H3-S10 and dimethylated H3-K9 peptides reduced mitotic kinase (Ipl1/ aurora) phosphorylation of the H3-S10 peptide in vitro, whereas acetylated H3-K9 and H3-K14 enhanced the phosphorylation (Rea et al., 2000) . Others have shown that the acetylated H3-K14 peptide did not affect RSK2 or PKA-dependent phosphorylation at lysine 10 of the unmodified H3 peptide in vitro, but did inhibit the phosphorylation of an unmodified H3 peptide (Lo et al., 2000) . Most likely, various kinases responsible for histone phosphorylation have different sensitivities to the acetylated H3 peptides. To clarify the relationship of multiple post-translational modifications, more experiments need to be done in vivo. EGF or EGF plus anisomycin-stimulated phosphorylation of histone H3 in C3H/10T1/2 cells was targeted to a small hyperacetylation-sensitive fraction after butyrate pretreatment for 5 h, and butyrate-induced acetylation did not increase the susceptibility of H3 to mitogen-stimulated phosphorylation in vivo (Barratt et al., 1994) . A recent report indicated that the phosphorylation signal of histone H3 at serine 10 induced by EGF plus anisomycin was essentially lost in TSA-pretreated C3H/10T1/2 cells (Clayton et al., 2000) , a finding that was similar to our observations (data not shown). Phosphorylation of hyperacetylated histone H3 at serine 10 has been shown (Clayton et al., 2000) . The modified sites for acetylation of histone H3 at lysine 9 and phosphorylation of H3 at serine 10 are in close proximity, and thus the antibody against phosphorylation of histone H3 at serine 10 may not be able to react. This has been demonstrated by Mahadevan's group (Clayton et al., 2000) . Although an antibody against both phosphorylation and acetylation of histone H3 at serine 10 and lysine 9 is available, we believe that in order to test the interdependence of the different modifications of H3, using only the antibody against acetylation of H3 at lysine 9 provides a clearer observation than the antibody that detects both phosphorylation and acetylation. Here, we reported that UVB treatment followed by TSA enhanced the phosphorylation of histone H3 at serine 28 in JB6 cells (Figure 5a,b) , whereas the level of phosphorylated histone H3 at serine 28 induced by UVB irradiation was not significantly affected by TSA pretreatment (Figure 5a,b) . These data support the view that HDACs inhibitor-induced hyperacetylation of histone H3 is not involved in histone H3 phosphorylation. In contrast, prephosphorylation of histone H3 at serine 28 by UVB promoted TSA-induced acetylation of histone H3 at lysine 9 (Figure 5c,d ). HATs such as yGCN5, PCAF, and p300, strongly enhanced acetylation of phosphorylated H3-S10 peptide in vitro (Cheung et al., 2000; Lo et al., 2000) . These results suggest that phosphorylation of histone H3 increases the susceptibility of H3 to HATs or HDACs inhibitors, although stimulators of phosphorylation, such as EGF or UVB irradiation, do not induce acetylation of histone H3.
Traditionally, TSA is known as an inhibitor of the HDACs. In the present study, we provide evidence that TSA strongly induces rapid and transient phosphorylation of histone H3 at serine 28. Phosphorylation of histone H3 at serine 28 promotes acetylation of histone H3 by TSA or HATs. TSA-induced post-translational modifications of histone H3 may cause chromatin remodeling to facilitate gene expression (Kijima et al., 1993; Yoshida et al., 1995; Davie and Chadee, 1998; Davie and Spencer, 1999; Sassone-Corsi et al., 1999; Spencer and Davie, 1999; Thomson et al., 1999) and a possible scheme is illustrated in Figure 6 .
Materials and methods

Cell lines and reagents
The JB6 mouse epidermal cell line C1 41 and its stable transfections, dominant negative mutant ERK2 (DNM-ERK2), p38 kinase (DNM-p38), and JNK1 (DNM-JNK1) were constructed as described previously (Huang et al., 1999a, b) . TSA and phenylmethylsulfonyl fluoride (PMSF) were purchased from Sigma (St Louis, MO, USA). PD98059 and SB202190 were from Calbiochem-Novabiochem Co. (La Jolla, CA, USA). Anti-rabbit IgG-conjugated alkaline phosphatase (AP) and antibodies against phosphorylated ERKs, p38 kinase, and JNKs were from New England Biolabs (Beverly, MA, USA). The antibody against phosphorylated H3 (serine 28) was produced and identified as described previously (Goto et al., 1999; Zhong et al., 2001b) . Anti-rat IgG-conjugated AP was from Pierce Co. (Rockford, IL, USA). The antibodies against b-actin, H3, and acetylated H3 (lysine 9) were from Upstate Biotechnology Inc. (Lake Placid, NY, USA). Fetal bovine serum (FBS) was from Gemini BioProducts (Calabasas, CA, USA). Minimal Eagle's essential medium (MEM) and l-glutamine were from Life Technologies, Inc (Grand Island, NY, USA). Gentamicin was from BioWhittaker Co. (Walkersville, MD, USA). Polyvinylidene difluoride (PVDF) membrane was from Millipore Co. (Bedford, MA, USA). The luciferase assay substrate was from Promega (Madison, WI, USA).
TSA treatment of JB6 cells
Equivalent numbers of JB6 cells were seeded in 10-cm dishes and cultured in 5% FBS/MEM until they reached 85-90% confluence. They were then starved in 0.1% FBS/MEM for 48 h with one change of medium after 24 h. Cells were incubated for 2 h in fresh 0.1% FBS/MEM, after which time they were or were not treated with TSA and then cultured for additional time periods. For TSA and UVB cotreatment, JB6 cells were first treated with TSA (30 ng/ml) for 2 h in fresh 0.1% FBS/MEM and then exposed to UVB (4 kJ/m 2 ), or JB6 cells were first exposed to UVB (4 kJ/m 2 ) and then treated with TSA (30 ng/ml) for additional time periods.
Acid-soluble protein extraction
After TSA treatment or UVB irradiation, cultured cells were harvested and washed two times with cold phosphate-buffered saline (PBS). Acid-solution protein extraction was carried out as described by the protocol of Upstate Biotechnology. In brief, acid-soluble proteins were extracted with lysis buffer (10 mm HEPES pH 7.9, 1.5 mm MgCl 2 , 10 mm KCl, 1.5 mm PMSF, 0.5 mm dithiothreitol) and then H 2 SO 4 was added to a final concentration of 0.2 m, and extractions were left for 60 min on ice. Supernatant fractions were transferred to fresh microcentrifuge tubes after centrifugation at 14 000 r.p.m. for 10 min in microcentrifuge and precipitated on ice for 45 min with a final concentration of 20% TCA. These tubes were centrifuged at 14 000 r.p.m. for 10 min at 41C and the pellets were then washed once with acidic acetone and then once with acetone. The acid-soluble proteins were stored at -201C until analysis. Figure 6 Schematic illustration of TSA-induced modifications of histone H3. TSA activates MAP kinases, ERKs, and p38 kinase, which results in the phosphorylation of histone H3 at serine 28. On the other hand, TSA inhibits HDACs, which increases acetylation of histone at lysine 9. TSA-induced modifications of histone H3 can cause chromatin remodeling and TSA may promote gene expression by increasing phosphorylation and acetylation of histone H3 and activity of some transcription factors. The arrows indicate activation and > indicates inhibition. A question mark indicates that the mechanism of the effect is unknown
Statistical analysis
Differences between the level of phosphorylation at serine 28 or acetylation at lysine 9 were analysed by using the Student's t-test. Po0.05 was considered significant. The results are expressed as mean7s.d.
Abbreviations
TSA, trichostatin A; HATs, histone acetyltransferases; HDACs, histone deacetylases; IE, immediate-early; EGF, epidermal growth factor; PMSF, phenylmethylsulfonyl fluoride AP, alkaline phosphatase; FBS, fetal bovine serum; MEM, minimal Eagle's essential medium; PVDF, polyvinylidene difluoride; PBS, phosphate-buffered saline.
